Correlation Between Altamira Therapeutics and Apollomics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Altamira Therapeutics and Apollomics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Altamira Therapeutics and Apollomics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Altamira Therapeutics and Apollomics Class A, you can compare the effects of market volatilities on Altamira Therapeutics and Apollomics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Altamira Therapeutics with a short position of Apollomics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Altamira Therapeutics and Apollomics.

Diversification Opportunities for Altamira Therapeutics and Apollomics

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Altamira and Apollomics is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Altamira Therapeutics and Apollomics Class A in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Apollomics Class A and Altamira Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Altamira Therapeutics are associated (or correlated) with Apollomics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Apollomics Class A has no effect on the direction of Altamira Therapeutics i.e., Altamira Therapeutics and Apollomics go up and down completely randomly.

Pair Corralation between Altamira Therapeutics and Apollomics

If you would invest (100.00) in Altamira Therapeutics on December 3, 2024 and sell it today you would earn a total of  100.00  from holding Altamira Therapeutics or generate -100.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy0.0%
ValuesDaily Returns

Altamira Therapeutics  vs.  Apollomics Class A

 Performance 
       Timeline  
Altamira Therapeutics 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Altamira Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, Altamira Therapeutics is not utilizing all of its potentials. The newest stock price disarray, may contribute to short-term losses for the investors.
Apollomics Class A 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Apollomics Class A has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of inconsistent performance in the last few months, the Stock's essential indicators remain very healthy which may send shares a bit higher in April 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Altamira Therapeutics and Apollomics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Altamira Therapeutics and Apollomics

The main advantage of trading using opposite Altamira Therapeutics and Apollomics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Altamira Therapeutics position performs unexpectedly, Apollomics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Apollomics will offset losses from the drop in Apollomics' long position.
The idea behind Altamira Therapeutics and Apollomics Class A pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.

Other Complementary Tools

Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Global Correlations
Find global opportunities by holding instruments from different markets
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities